Eli Lilly sponsors Vogue World Milan event while selling weight-loss drugs
American pharmaceutical company Eli Lilly is listed as a sponsor for the fifth Vogue World fashion show held in Milan on Tuesday night.
Sponsorship and criticism arise
The American firm manufactures weight-loss medications including Mounjaro and the Foundayo pill. Critics argue that pairing high-profile fashion events with a drug maker promotes thinness as an aspirational goal. Eating disorder charities have warned about the negative impact of this partnership on body image.
Previous collaborations continue
Eli Lilly also sponsored the 2025 Vogue World event in Hollywood earlier this year. The company supported the Met Gala livestream which featured a promotional video with actor Patrick Schwarzenegger. This ongoing partnership does not explicitly link specific drugs to the fashion brand.
Academic concerns grow
Charlotte Markey, a professor of psychology at Rutgers University, stated that thinness is being positioned as something medically achievable. She noted that the fashion industry habitually casts very thin models in catwalk shows and editorials. These groups believe the marriage of these industries suggests thinness should be explicitly aspired to.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.